EPO Patents = 2

Trademarks = 2

Forward Citations = 87

Loading Chart...

6 inventors (with patents filed for the assignee):

Alan R Meyer (9 out of 13 patents)

William H Pitlick (3 out of 8 patents)

Konstantinos Charizanis (3 out of 8 patents)

4. Mina Sooch (3 out of 8 patents)

5. Bernhard Hoffmann (3 out of 7 patents)

6. Daniela Carmen Oniciu (2 out of 16 patents)

11 patents: Sort by Forward Citations

1. 12016841 - Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders (2024-06-25),

2. 11976044 - Highly pure phentolamine mesylate (2024-05-07),

3. 11844858 - Aqueous ophthalmic solutions of phentolamine and medical uses thereof (2023-12-19),

4. 11717510 - Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance (2023-08-08),

5. 11566005 - Highly pure phentolamine mesylate and methods for making same (2023-01-31),

6. 11400077 - Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders (2022-08-02),

7. 11090261 - Aqueous ophthalmic solutions of phentolamine and medical uses thereof (2021-08-17),

8. 11000509 - Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance (2021-05-11),

9. 10993932 - Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders (2021-05-04),

10. 10772829 - Aqueous ophthalmic solutions of phentolamine and medical uses thereof (2020-09-15),

11. 10278918 - Aqueous ophthalmic solutions of phentolamine and medical uses thereof (2019-05-07),

Company Overview

Ocuphire Pharma, Inc. is a clinical-stage biopharmaceutical company based in West Bloomfield, Michigan, focused on developing innovative therapies for eye diseases. The company specializes in advancing treatments aimed at addressing unmet medical needs in ophthalmology, particularly in areas such as diabetic retinopathy and presbyopia. Through its research and development efforts, Ocuphire aims to enhance patient outcomes and improve vision health, leveraging cutting-edge science and technology in the field of eye care.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

11 Patents

#3 in West Bloomfield, MI

#964 in Michigan

#27,514 in US

#51,761 in the World

West Bloomfield, MI, United States of America

Ocuphire Pharma, Inc.

Forward Citations = 87

6 inventors:

Alan R Meyer (9 out of 13 patents)

William H Pitlick (3 out of 8 patents)

Konstantinos Charizanis (3 out of 8 patents)

4. Mina Sooch (3 out of 8 patents)

5. Bernhard Hoffmann (3 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ocuphire Pharma, Inc.. Retrieved from https://idiyas.com/company/ocuphire-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]